EviCore updates its insurance coverage guidelines to reimburse AI software for analyzing coronary CT angiography (CCTA) images.
Key Details
- 1EviCore now recommends reimbursement for AI-based CCTA analysis from Cleerly, Heartflow, and Elucid.
- 2Guidelines apply to acute or stable chest pain patients and those with noted coronary stenoses.
- 3Policy takes effect October 1, 2024.
- 4Follows Medicare's recent approval and expanded payment for AI-backed CCTA analyses, now covering over 70% of Medicare patients.
- 5CMS doubled hospital/outpatient reimbursement for cardiac CT scans to $357.13 as of January 2024.
Why It Matters
Expanded payer coverage accelerates the clinical adoption of AI-powered CCTA, increasing access and incentives for hospitals to implement these advanced tools, which can aid early detection and personalized treatment for cardiac patients.
Source
Radiology Business
Related News
•Radiology Business
Aidoc Receives FDA Breakthrough Status for Multi-Condition CT AI Triage
Aidoc has received FDA Breakthrough Device status for its AI solution that flags multiple critical conditions in CT scans.
•AI in Healthcare
FDA Seeks Real-World Performance Insights on AI Medical Devices
FDA calls for healthcare worker feedback to enhance monitoring of AI-enabled medical devices in real-world settings.
•Radiology Business
AI Triage Cuts CT Report Turnaround for Pulmonary Embolism—Daytime Only
FDA-backed study finds AI triage tools reduce radiology CT report turnaround times for pulmonary embolism during peak hours.